Breaking News

PTC Therapeutics, Blackstone Enter $1B Strategic Financing Pact

PTC will leverage Blackstone's network and life sciences expertise in an effort to bring at least one therapy to market every 2-3 years.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PTC Therapeutics, Inc. has entered into a strategic financing collaboration with funds managed by Blackstone to support its mission to reach a steady-state of delivering at least one therapy every 2-3 years to continue to bring medicines to market. As part of the collaboration, funds managed by Blackstone Life Sciences and Blackstone Credit will provide PTC with an initial $500 million commitment, including $350 million in low-cost, low-dilution capital at close.   “This strategic financ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters